ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE) | Finanzwire

Basculer en Français

10562	Companies
223480	Keywords
152494	Articles
118263	Press releases

Headlines Articles Press releases ORPHAN SYNERGY EUROPE-PHARMA

Home
Companies
ORPHAN SYNERGY EUROPE-PHARMA

BRIEF

published on 06/03/2026 at 20:34, 9 days 16 hours ago

OSE Immunotherapeutics General Assembly: access to preparatory documents

Shareholders Paris General Assembly Preparatory Documents OSE Immunotherapeutics
BRIEF

published on 06/03/2026 at 20:34, 9 days 16 hours ago

OSE Immunotherapeutics to Hold Annual General Meeting on June 24, 2026

Annual General Meeting Shareholder Information OSE Immunotherapeutics Webcast Access Paris Event
PRESS RELEASE

published on 06/03/2026 at 20:29, 9 days 16 hours ago

Annual General Meeting on June 24, 2026 Procedures for obtaining preparatory documents for the General Meeting
OSE Immunotherapeutics SA announces Annual General Meeting on June 24, 2026, with procedures for obtaining preparatory documents. Meeting details and documents available on company website

Annual General Meeting Shareholders French Commercial Code Preparatory Documents OSE Immunotherapeutics
BRIEF

published on 06/03/2026 at 20:24, 9 days 16 hours ago

OSE Immunotherapeutics: Publication of 2025 Financial Results

Universal Registration Document OSE Immunotherapeutics Funding Strategy 2025 Financial Results IRIS Funding
BRIEF

published on 06/03/2026 at 20:24, 9 days 16 hours ago

OSE Immunotherapeutics Reports 2025 Financial Results and Universal Registration Document Filing

Universal Registration Document OSE Immunotherapeutics Cash Runway 2025 Financial Results IRIS Financing
PRESS RELEASE

published on 06/03/2026 at 20:19, 9 days 16 hours ago

OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration Document
OSE Immunotherapeutics reports full year 2025 audited consolidated financial results and filing of 2025 Universal Registration Document, confirming cash runway with IRIS Financing

Universal Registration Document OSE Immunotherapeutics Cash Runway 2025 Financial Results IRIS Financing
BRIEF

published on 05/28/2026 at 21:09, 15 days 15 hours ago

OSE Immunotherapeutics Secures Flexible Bridge Equity Financing

Strategic Plan Clinical Development Institutional Investors Share Issuance Flexible Financing
PRESS RELEASE

published on 05/28/2026 at 21:04, 15 days 15 hours ago

OSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing
OSE Immunotherapeutics announces a flexible bridge equity financing with IRIS Capital Investment to raise €19.3 million, extending cash runway to December 2026 as part of a global financing strategy

OSE Immunotherapeutics Cash Runway Extension Bridge Equity Financing IRIS Capital Investment Global Financing Strategy
BRIEF

published on 05/22/2026 at 07:35, 22 days 5 hours ago

OSE Immunotherapeutics Announces Positive Results in Ovarian Cancer Trial

Ovarian Cancer Clinical Trial Results OSE Immunotherapeutics Tedopi® TEDOVA Phase 2
PRESS RELEASE

published on 05/22/2026 at 07:30, 22 days 5 hours ago

OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer
OSE Immunotherapeutics announces positive topline results from TEDOVA Phase 2 trial with Tedopi® in recurrent ovarian cancer, presenting at ASCO 2026. Combination with pembrolizumab improves progression-free survival

OSE Immunotherapeutics Tedopi TEDOVA Phase 2 ASCO 2026 Recurrent Ovarian Cancer

1 2 ... 7

Accesswire

Published on 06/13/2026 at 04:50, 7 hours 45 minutes ago

BTU Additional Details Regarding Recent Acquisition
Published on 06/13/2026 at 02:00, 10 hours 35 minutes ago

Battery X Metals Appoints Automotive Industry Professional from Canadian Subsidiary of One of the World's Leading Premium Automobile Manufacturers, Headquartered in Munich, Germany, to its Advisory Board to Advance Commercialization of Its Patent-Pending
Published on 06/12/2026 at 23:15, 13 hours 20 minutes ago

BioNxt Announces Non-Brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/12/2026 at 22:30, 14 hours 5 minutes ago

Fox River Provides Reminder To Vote And Updated Dissent Rights
Published on 06/12/2026 at 15:14, 21 hours 21 minutes ago

Reeflex Solutions Inc. Reports Voting Results From Annual and Special Meeting of Shareholders

View all ACCESSWIRE

EQS Group

Published on 06/13/2026 at 08:18, 4 hours 16 minutes ago

EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S expands AI substrate capacity in Kulim and increases outlook for 2026/27
Published on 06/13/2026 at 01:05, 11 hours 29 minutes ago

OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe
Published on 06/12/2026 at 22:50, 13 hours 44 minutes ago

Bitmine Immersion Technologies Announces Initial Dividends and NYSE Listing for Series A Preferred Stock
Published on 06/12/2026 at 21:00, 15 hours 34 minutes ago

Partners Group statement regarding its evergreen vehicles
Published on 06/12/2026 at 20:22, 16 hours 12 minutes ago

Rumble Announces Discontinuation of Trading in Tendered Northern Data Shares (ISIN DE000A41YEL8) in the Exchange Offer

Les Echos

Published on 06/12/2026 at 18:31, 18 hours 3 minutes ago

Share retention commitments (Dutreil agreement)
Published on 06/12/2026 at 10:34, 1 day 2 hours ago

CHANGE IN THE SHARE CAPITAL
Published on 06/12/2026 at 09:00, 1 day 3 hours ago

Pricing of Green Senior Secured Notes due 2031 by Neoen FINCO PLC
Published on 06/11/2026 at 20:30, 1 day 16 hours ago

Mersen joins the SBF 120 index
Published on 06/11/2026 at 17:45, 1 day 18 hours ago

BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026

View all LES ECHOS COMFI WIRE